Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2”

Showing 20 of 0 results

Not applicableUnknownNCT03597243
What this trial is testing

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation

Who this might be right for
HIV/AIDSHSV-2 Infection
National Institute for Medical Research, Tanzania 3,120
Testing effectiveness (Phase 2)Study completedNCT00158509
What this trial is testing

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Who this might be right for
Herpes GenitalisHIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 215
Not applicableStudy completedNCT02910284
What this trial is testing

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 140
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT00076232
What this trial is testing

Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Who this might be right for
HIV InfectionsHIV SeronegativityHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Post-approval studies (Phase 4)Study completedNCT00723229
What this trial is testing

Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Who this might be right for
Genital Herpes
University of Washington 48
Early research (Phase 1)Study completedNCT02571166
What this trial is testing

HSV529 Vaccine in HSV-2 Seropositive Adults

Who this might be right for
Herpes Simplex Virus 2
Fred Hutchinson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01580995
What this trial is testing

Herpes Simplex Type 1 Suppression in Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 19
Large-scale testing (Phase 3)UnknownNCT01068015
What this trial is testing

(Men Who Have Sex With Men) MSM Community Intervention Trial

Who this might be right for
HIVSyphilisHerpesvirus 2, Human
National Center for AIDS/STD Control and Prevention, China CDC 3,214
Not applicableStudy completedNCT04205721
What this trial is testing

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

Who this might be right for
HSV-2 InfectionHIV InfectionsPregnancy Related
University of North Carolina, Chapel Hill 23,061
Not applicableStudy completedNCT03868644
What this trial is testing

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

Who this might be right for
HIV/AIDSHSV-2 Infection
Abdul Latif Jameel Poverty Action Lab 10,646
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04979975
What this trial is testing

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 200
Post-approval studies (Phase 4)Study completedNCT00158860
What this trial is testing

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Who this might be right for
Herpes Genitalis
GlaxoSmithKline 384
Large-scale testing (Phase 3)Study completedNCT00209313
What this trial is testing

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

Who this might be right for
HIV-1 and HSV-2 CoinfectionHIV Infections
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00378976
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Who this might be right for
HIV InfectionHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02300142
What this trial is testing

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 37
Not applicableStudy completedNCT00655434
What this trial is testing

HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population

Who this might be right for
Herpes Simplex Virus 2
Focus Diagnostics, Inc. 400
Early research (Phase 1)Study completedNCT01453075
What this trial is testing

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 31
Large-scale testing (Phase 3)Study completedNCT00332878
What this trial is testing

Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities

Who this might be right for
HIV Infections
Medical Research Council, South Africa 2,801
Not applicableStudy completedNCT00495573
What this trial is testing

HSV-2 Shedding Resolution After Acyclovir Treatment

Who this might be right for
Genital Herpes
University of Washington 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation